Özlem Türeci

Özlem Türeci, born on March sixth, nineteen sixty-seven, is a distinguished German physician and immunologist renowned for her groundbreaking contributions to biotechnology. In two thousand eight, she co-founded BioNTech, a pioneering company that has made significant strides in the field of personalized medicine.

As the chief medical officer of BioNTech since two thousand eighteen, Türeci has played a pivotal role in the development of innovative therapies. Her most notable achievement came in two thousand twenty when her team developed the first messenger RNA-based vaccine approved for use against COVID-19, marking a significant milestone in the fight against the pandemic.

In addition to her entrepreneurial endeavors, Türeci has also made her mark in academia. Since two thousand twenty-one, she has held the position of Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology and Johannes Gutenberg University Mainz, where she continues to inspire the next generation of scientists.

Türeci's remarkable journey is complemented by her partnership with her spouse, Uğur Şahin, with whom she has shared numerous accolades and awards, recognizing their contributions to science and public health.